SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-021314
Filing Date
2017-11-03
Accepted
2017-11-02 18:01:25
Documents
53
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cort-10q_20170930.htm 10-Q 1186170
2 EX-10.1 cort-ex101_392.htm EX-10.1 298205
3 EX-10.2 cort-ex102_393.htm EX-10.2 34158
4 EX-31.1 cort-ex311_6.htm EX-31.1 15335
5 EX-31.2 cort-ex312_8.htm EX-31.2 15334
6 EX-32.1 cort-ex321_7.htm EX-32.1 6739
7 EX-32.2 cort-ex322_9.htm EX-32.2 6582
  Complete submission text file 0001564590-17-021314.txt   4224737

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cort-20170930.xml EX-101.INS 781950
9 XBRL TAXONOMY EXTENSION SCHEMA cort-20170930.xsd EX-101.SCH 30621
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cort-20170930_cal.xml EX-101.CAL 44517
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cort-20170930_def.xml EX-101.DEF 49015
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20170930_lab.xml EX-101.LAB 214412
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20170930_pre.xml EX-101.PRE 156488
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 171173932
SIC: 2834 Pharmaceutical Preparations